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Abstract. Thirty-two patients with fertility problems were
identified as carriers of small supernumerary marker
chromosomes (sSMC). Molecular cytogenetic techniques
were used to characterize their chromosomal origin. Together
with the other cases available in the literature 111 sSMC
cases have now been detected in connection with fertility
problems in otherwise clinically healthy persons and
characterized for their genetic content. According to this
study, in 60% of the cases the sSMC originated from
chromosomes 14 or 15. Euchromatic imbalances were caused
by the sSMC presence in 30% of the cases. Notably, in 53%
of infertile sSMC carriers, the sSMC was parentally trans-
mitted. As we found indications of an as yet unknown
mechanism for the elimination of sSMC from the human
gene pool, sSMC could also play a role in elucidating the
process of chromosome gain and loss during evolution.
Nonetheless, further detailed molecular analysis will be
necessary in the future to characterize the mechanisms and
genetic basis for this phenomenon.
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Introduction
Patients with fertility problems are known to be a clinically
heterogeneous group as a variety of factors can influence
fertility. Apart from hormone status, age, exercise, obesity,
infectious disease, immunological or psychological factors,
fertility problems can result from surgery or blockage, or be
associated with defined abnormalities in the gametes, such as
azoospermia or oligoasthenoteratozoospermia syndrome
(OAT) (1,2). Fertility problems and/or infertility are defined
as the inability to conceive after one year of regular
unprotected intercourse and manifest in one in six couples
wishing to start a family. In about 20% of couples the reason
for infertility remains ‘unexplained’ (2).
As most, if not all, of the aforementioned factors of
infertility are likely to have genetic components it is difficult
to accurately assess the corresponding genetic contribution.
Nevertheless, genetic and/or karyotypic analysis has revealed
the association of specific (cyto)genetic conditions with
fertility problem phenotypes, such as mutations in the cystic
fibrosis (CFTR) gene, mutations or microdeletions in Y
chromosome genes, or the presence of constitutional numerical
or structural chromosomal aberrations (1). The latter, such as
sex chromosome aberrations, and the presence of constitu-
tional inversions, translocations or small supernumerary
marker chromosomes (sSMC) (3), can lead both to fertility
problems and repeated abortions (1). The rate of sSMC
presence in the normal population was recently determined to
be 0.044%, but elevated to 0.125% in infertile groups.
Distributing the latter group into male and female, there is a
gender-specific 7.5:1 difference in sSMC frequency (4).
Here we present the, to our knowledge, largest molecular
cytogenetic study on otherwise healthy persons with fertility
problems and an sSMC. Nineteen male and 13 female
carriers were studied. All of them had a history of repeated
abortions, amenorrhea, unexplained infertility and/or had
undergone intracytoplasmatic sperm injected treatment (ICSI).
The origin and genetic content of the sSMC were charac-
terized in detail and are discussed with the other 79 cases
from the literature.
Materials and methods
Cytogenetics. All individuals included in Table I were
clinically healthy, apart from fertility problems. A banding
cytogenetic technique was performed according to standard
procedures on peripheral blood samples (5) of the 32 patients
summarized in Table I. Fifteen to 25 metaphases were
analyzed per patient. 
Molecular cytogenetics. The applied multicolor FISH
(mFISH) approaches have also been previously described in
detail: centromere-specific mFISH (cenM-FISH) (6) and
subcentromere-specific mFISH (subcenM-FISH) (7) were
used to characterize the sSMC (see Table I and Fig. 1).
Database search. All sSMC in infertile subjects, charac-
terized for their chromosomal origin and reported in the
literature were included in Table I. This data was obtained
from the sSMC database (8).
AZF deletion status in males. Unfortunately no information
was available on the AZF deletion status in male subjects
reported in the literature, or in those included here as new
cases.
Results
The results obtained in the 32 new sSMC cases with fertility
problems are summarized, together with the data from the
literature in Table I. Cases 3, 5, 7, 9, 12, 16-23, 32-38, 69,
71, 72, 74, 75, 81, 96, 103, 104, 110 and 111 are reported
here for the first time and were characterized comprehensively
for their chromosomal origin and genetic content by cenM-
and subcenM-FISH. Examples of sSMC characterization are
given in Fig. 1 for cases 7, 17 and 37.
Together with the 79 other cases from the literature (8),
making a total of 111 cases, the sSMC detected due to
fertility problems were characterized for their chromosomal
origin. Examples for all 24 human chromosomes apart from
chromosomes 4, 10, 11, 13, 19 and X were found (Fig. 2a).
In the majority the sSMC derived from an acrocentric
chromosome. Overall, 60% of the sSMC cases originated
from chromosomes 15 or 14 (Fig. 2b).
Apart from cases 11, 14, 24, 40-45, 82-93, 97, 98, 105 and
109, all sSMC were characterized in detail for their genetic
content. The euchromatic regions showing imbalances due to
sSMC presence are summarized in Fig. 2c. For case 10
euchromatin was also detected in an sSMC(6), however, no
imbalances were induced by sSMC presence, as there was a
corresponding deletion of a chromosome 6.
The reasons for which the cytogenetic studies were
performed in the 111 patients are listed by case in Table I,
and summarized in Fig. 3a. In Figs. 3-6 the cases were divided
into four groups as follows: (i) OAT, comprised of males with
oligoasthenoteratozoospermia or similar fertility problems
associated with numerically and/or morphologically altered
sperm; (ii) ‘amenorrhea’, comprised of females suffering from
amenorrhea or similar clinical conditions; (iii) RAB,
comprised of patients with repeated abortions in partnership,
and (iv) FP, comprising the remainder with ‘unexplained
infertility’. In Fig. 3a these groups are separated by gender.
Overall, the most common indication was ‘unexplained
infertility/fertility problems’ (FP), followed by ‘repeated
abortions’ (RAB), OAT syndrome/azoospermia, and amenor-
rhea. As seen in Fig. 3b amenorrhea and defined abnormalities
in the gametes are more likely to appear when the sSMC
originates from an acrocentric chromosome. Repeated
abortions and unexplained infertility were found in about the
same frequency in both groups.
The parental origin incidence of sSMC in cases with
fertility problems is summarized in Fig. 4; the relevant
information was available for 36 of the cases in Table I.
Unexpectedly, 53% of the sSMC detected in connection with
fertility problems were derived from the parents. Maternally
derived sSMC occurred 1.6 times more frequently than
paternally derived sSMC (Fig. 4). Eighty-eight percent of
the inherited sSMC were derived from an acrocentric
chromosome (see Table I). In so-called ‘familial cases’ the
sSMC was proven to have been carried through more than
one generation; but either no information on paternal or
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maternal passage was provided, or it changed from grand-
paternal to maternal (case 77).
In patients with fertility problems there is a tendency
towards gender-specific differences in the offspring (Fig. 5a):
a maternally inherited sSMC is more likely to lead to fertility
problems in sons than in daughters and vice versa for father
and daughter. All inherited sSMC cases not detected in
connection with fertility problems are summarized in Fig. 5b,
and a nearly 1:1 sex ratio in the resulting children can be
observed.
There is also a tendency towards repeated abortions and
OAT in inherited compared to de novo sSMC (Fig. 6).
Discussion
Chromosomal origin of sSMC in infertile patients. In the
present study 32 new sSMC patients with fertility problems
were added to 79 single-case reports from the literature. The
sSMC were characterized for their chromosomal origin for
all 111 cases. At present an involvement of only 19 of the 24
human chromosomes has been described in connection with
fertility problems and sSMC-formation. Before the present
study no sSMC[5] or sSMC[12] had been reported within
this group of patients. Thus, as soon as more cases are
comprehensively characterized, it is to be expected that
examples for the remaining 5 chromosomes will also be
observed in patients with fertility problems.
In cases 110 and 111 the exact chromosomal origin could
not be determined; as the sSMC were stainable only by a
probe specific for the acrocentric p-arms they were described
as inv dup(acro). In these two cases the amount of alphoid
DNA sequences on the sSMC was too small to be detected
by FISH. A similar observation was previously described for
a case of an sSMC[5] (9). In the latter the presence of
D1/5/19Z1 sequences was confirmed by microdissection and
reverse FISH. This approach could not be applied in the
present cases due to lack of material.
In 78% of the cases with fertility problems summarized
here, the sSMC derived from an acrocentric chromosome
(Table I and Fig. 2a). Even focusing only on parentally
derived sSMC (see below), 88% of the cases were derived
from an acrocentric chromosome (Table I). This rate is similar
for the overall population [~70% according to (3)]. Also it
was not unexpected that sSMC[15] was the most frequently
observed (4,8). However, the sSMC[14] rate in the infertile
patients from the present study was, at 15%, ~4 times higher
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Figure 1. Examples of results obtained by cenM-FISH and subcenM-FISH in cases 7, 17 and 37, according to Table I. (a) cenM-FISH (left) revealed that the
sSMC in case 7 originated from chromosome 3 (arrowhead); subcenM-FISH (right) demonstrated that there was a mosaic karyotype, min(3)(:p12.1-
>q11.1~11.2:) [55]/min(3)(:p11.1->q11.1~11.2::q11.1~11.2->p11.1:)[2]. (b) and (c) subcenM-FISH characterized in case 17 a min(12)(:p12.1~12.2->q10:)
and in case 37 two identical inv dup(14)(q11.1). cep, centromeric probe; p, short arm; pcp, partial chromosome painting probe; q, long arm.
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than in all sSMC cases studied for their chromosomal origin
(3,4,8) (Fig. 2b). At present there is no explanation for this
observation. Nonetheless it can be concluded, that after
sSMC detection in connection with unexplained infertility in
~60% of cases the origin of the sSMC can be characterized
by application of the centromere-specific probes for chromo-
somes 14 and 15.
Genetic content of sSMC in infertile. Eighty-seven of the 111
sSMC cases summarized in Table I were characterized
comprehensively for their genetic content. In summary, no
genetic imbalance was present in 70% of the cases, since
exclusively heterochromatic material was detected on the
sSMC. Small centomere-near partial tri-, tetra- or even
hexasomies were observed in the remaining 30% of the
cases. Euchromatin, and thus, an imbalance could be caused
by any of the 13 chromosomes depicted in Fig. 2c. It is well
known that euchromatic imbalances do not necessarily lead
to clinical effects (10). This has also been reported specifically
for sSMC (11). However, a contribution of at least some of
these regions to infertility/fertility problems cannot be
disregarded at present.
Parental origin of the sSMC. As summarized in Fig. 4, 53%
of the sSMC detected in connection with fertility problems
were derived from one of the parents; for two of these cases
euchromatin presence was proven (cases 59-60). Maternally
derived sSMC occurred more frequently than paternally
derived sSMC, an observation consistent with the recently
outlined fact that familial sSMC are predominantly inherited
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Figure 2. (a) Chromosomal distribution of sSMC in infertile patients depicted by gender, based on the data from Table I. (b) Percentage of sSMC[14] and
sSMC[15] according to (8) (green bars) compared to the rate of the corresponding chromosomes in infertile patients (blue bars). Chromosome 14 is clearly
over-represented among the latter. (c) Ideograms of the centromere-near regions of chromosomes 1-3, 5, 8, 9, 12, 14, 15, 17, 18, 20 and 21. The black bars
show the maximal size of imbalances detected in the 111 patients with fertility problems, i.e. chromosomal regions for which a causative connection to
fertility problems cannot completely be disregarded.
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via the maternal line (12). Unfortunately, no information was
available as to whether fertility problems were already
present in the parents of the sSMC carriers who had inherited
an sSMC from one of the parents.
According to population studies otherwise healthy
persons with unexplained infertility have a ~2.9-fold
enhanced risk for detection of an sSMC during cytogenetic
analysis compared to the general population (13). Thus, the
fact that familial sSMC can be detected in connection with
fertility problems in >50% was unexpected.
Analyzing this finding further (Figs. 5-6) there appeared
to be gender-specific differences for the children: a maternally
inherited sSMC was more likely to be detected in a son with
fertility problems than in daughters and vice versa for
paternally inherited sSMC. Even though the available data is
small (17 cases in infertile sSMC carriers) the tendency
seems to be clear compared to carriers of familial sSMC
detected due to reasons other than fertility problems (Fig. 5).
As demonstrated in Fig. 6 compared to de novo sSMC
there is also a slight tendency towards repeated abortions or
OAT in inherited sSMC.
Reasons for fertility problems in the studied sSMC carriers.
The mechanisms by which sSMC presence influences fertility
are not really understood at present. However, for cases 10,
108 and 109, it can be speculated that the chromosomal
aberration led to an even more imbalanced, and subsequently
unviable, situation in the potential offspring, than that present
in the sSMC carriers themselves.
For the other cases a direct correlation of sSMC presence
and fertility problems is not easy to evoke, especially, as for
most cases, no clear clinical indication is provided: in most
cases the diagnosis was ‘unexplained infertility/fertility
problems’ (32-47% in male and female) or repeated abortions
in partnership (26-37%, see Fig. 3a). Overall, different kinds
of sSMC are detectable in the heterogeneous group of
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Figure 6. The cases from Table I separated by their origin into familial and
de novo cases and aligned with the clinical reason for the cytogenetic
studies. all FP, cases with unexplained infertility including amenorrhea;
OAT, oligoasthenoteratozoospermia syndrome and other defined abnor-
malities in the gametes (e.g. azoospermia); RAB, repeated abortions.
Figure 5. Infertile carriers of an inherited sSMC according to Table I (a),
compared in a gender-specific way with all other carriers of an inherited
sSMC according to (8) (b). The absolute number of available cases for this
comparison is given in small black numbers in the right upper edge of the
differentially colored column fields.
Figure 4. Parental origin of the sSMC in 36 of the 111 cases listed in Table I,
where corresponding information was available. fam, familial; mat,
maternal; pat, paternal.
Figure 3. Distribution of reasons for fertility problems in the 111 patients
with sSMC, divided by gender (a) and by chromosomal origin (b). Due to
the small number of cases available  only a distinction between acrocentric-
and non-acrocentric-derived chromosomes was possible. FP, cases with
unexplained infertility; n, number of cases; OAT, oligoasthenoterato-
zoospermia syndrome; others, other defined abnormalities in the gametes
(e.g. azoospermia); RAB, repeated abortions.
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Table I. All cases with well defined sSMC detected in otherwise normal patients with fertility problems as characterized in this
study and available from the literature.a
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Case GTG-result Parental FISH result Clinical findings sSMC no.
no. origin according to (8)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
1 47,XY,+mar[100%] de novo r(1)(::p11->q11::) RAB in female partner 01-O-p11.1/1-2
2 47,XX,+mar[40%]/ de novo r(1)(::p11->q11::) FP 01-O-p11.1/1-3
46,XX[60%]
3b 47,XY,+mar[100%] n.a. min(1)(:p11.2->q12:) RAB in female partner 01-O-p11.1/3-1
4 47,XY,+mar[52%]/ de novo r(2)(::p11.1->q11.2::) FP, ICSI 02-O-p11.1/1-1
46,XY[48%]
5b 47,XX,+mar[60%]/ n.a. r(2)(::p11.1->q11.2::)[7]/ FP 02-O-p11.1/1-3
46,XX[40%] r(2;2)(::p11.1->q11.2:
:p11.1->q11.2::)[2]
6 47,XY,+mar[100%] n.a. min(3)(:p12.2->q11.1:) FP, ICSI 03-O-p12.2/1-1
7b 47,XY,+mar[30%]/ n.a. min(3)(:p12.1->q11.1~11.2:)[55]/ FP with cryptorchidism, 03-O-p12.1/1-1
46,XY[70%] min(3)(:p11.1->q11.1~11.2 small testes, umbilical
::q11.1~11.2->p11.1:)[2] and inguinal hernia.
8 47,XX,+mar[20%]/ n.a. r(3) RAB 03-CO-3
46,XX[80%]
9b 47,XX,+mar[100%] n.a. min(5)(:p12->q11.1:) FP, ICSI 05-O-p12/1-1
10 47,XY,del(6)(p22.3q10), n.a. r(6)(::p22.3->q10::) FP 06-O-p22.3/1-1
+r(6)(::p22.3q10::)[100%]
11 47,XY,+mar[?%]/ de novo dic(7) FP 07-CO-1
46,XY[?%]
12b 47,XY,+mar[40%]/ n.a. min(8)(:p11.1->q11.21:)[9]/ FP, ICSI 08-O-p11.1/1-1
46,XY[60%] min(8)(:p11.21->q11.1:)[5]
13 47,XY,+mar[45%]/ de novo r(8)(::p10->q12::) RAB in female partner 08-O-p10/1-1
46,XY[55%]
14 47,XX,+mar[?%]/ n.a. mar(8) RAB 08-CO-3
46,XX[?%]
15 47,XX,+mar[75%]/ de novo r(9)(::p12->q10::) RAB 09-O-p12/1-2
46,XX[25%]




17b 47,XY,+mar[66%]/ n.a. min(12)(:p12.1~12.2->q10:) FP, ICSI 12-O-p12.1~12.2/1-1
46,XY[34%]
18b 47,XY,+mar[100%] n.a. inv dup(13or21)(q10) FP, ICSI 13/21-O-q10/1-3
19b 47,XX,+mar[50%]/ n.a. min(13or21)(q10) FP, ICSI 13/21-O-q10/2-2
46,XX[50%]
20b 47,XY,+mar[100%] n.a. inv dup(13)(q11) or FP 13/21-O-q11/2-2
inv dup (21)(q11.1)
21b 47,XX,+mar[100%] n.a. inv dup(13)(q11) or RAB 13/21-O-q11/2-3
inv dup (21)(q11.1)
22b 47,XY,+mar[100%] n.a. inv dup(13)(q11) or RAB in female partner 13/21-O-q11/2-4
inv dup (21)(q11.1)
23b 47,XY,+mar[100%] n.a. inv dup(13)(q11) or OAT 13/21-O-q11/2-6
inv dup (21)(q11.1)
24 47,XX,+mar [100%] n.a. mar(13 or 21) RAB 13/21-CO-5
25 47,XY,+mar[100%] de novo inv dup(14)(q10) FP, ICSI 14-O-q10/1-2
26 47,XY,+mar[100%] n.a. inv dup(14)(q10) OAT. ICSI 14-O-q10/1-3
27 47,XY,+mar[100%] n.a. inv dup(14)(q10) OAT, ICSI 14-O-q10/1-4
28 47,XY,+mar[100%] n.a. inv dup(14)(q10) OAT 14-O-q10/1-13
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Table I. Continued.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Case GTG-result Parental FISH result Clinical findings sSMC no.
no. origin according to (8)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
29 47,XY,+mar[100%] n.a. inv dup(14)(q10) FP 14-O-q10/1-14
30 47,XX,+mar[86%]/ n.a. inv dup(14)(q11.1) FP, ICSI 14-O-q11.1/1-1
46,XX[14%]
31 47,XX,+mar[100%] n.a. inv dup(14)(q11.1) FP 14-O-q11.1/1-2
32b 47,XY,+mar[100%] n.a. inv dup(14)(q11.1) OAT 14-O-q11.1/1-3
33b 47,XY,+mar[100%] n.a. inv dup(14)(q11.1) FP, ICSI 14-O-q11.1/1-6
34b 47,XY,+mar[100%] n.a. inv dup(14)(q11.1) RAB 14-O-q11.1/1-8
35b 47,XX,+mar[100%] Maternal inv dup(14)(q11.1) RAB 14-O-q11.1/1-10
36b 47,XY,+mar[100%] n.a. inv dup(14)(q11.1) FP 14-O-q11.1/1-11
37b 48,XX,+2mar[100%] n.a. inv dup(14)(q11.1) Amenorrhea 14-O-q11.1/2-2
38b 47,XX,+mar[40%]/ n.a. min(14)(pter->q11.2:) Oligomenorrhea 14-O-q11.2/3-1
46,XX[60%]
39 47,XY,+mar[100%] n.a. r(14)(::p11.2->q11.2::) FP, oligospermia 14-O-q11.2/4-1
40 47,XX,+mar[100%] n.a. mar(14) FP 14-CO-10
41 47,XX,+mar[100%] de novo mar(14) Amenorrhea 14-CO-11
42 47,XY,+mar[100%] n.a. mar(14 or 22) OAT 14/22-CO-11
43 47,XY,+mar[100%] n.a. mar(14 or 22) FP in female partner 14/22-CO-29
44 47,XY,+mar[100%] n.a. mar(14 or 22) Astenozoospermia 14/22-CO-30
45 47,XY,+mar[?%] n.a. mar(14 or 22) RAB in female partner 14/22-CO-31
46 47,XY,+mar[100%] de novo inv dup(15)(q10) RAB 15-O-q10/1-2
47 47,XY,+mar[100%] n.a. inv dup(15)(q11) RAB in female partner 15-O-q11/1-18
48 47,XX,+mar[100%] n.a. inv dup(15)(q11) RAB 15-O-q11/1-19
49 47,XX,+mar[100%] n.a. inv dup(15)(q11) RAB 15-O-q11/1-20
50 47,XX,+mar[100%] Paternal inv dup(15)(q11) Amenorrhea 15-O-q11/1-21
51 47,XX,+mar[100%] Paternal inv dup(15)(q11) RAB 15-O-q11/1-23
52 47,XX,+mar[100%] n.a. inv dup(15)(q11) FP 15-O-q11/1-26
53 47,XY,+mar[100%] n.a. inv dup(15)(q11) FP 15-O-q11/1-31
54 47,XX,+mar[100%] Paternal inv dup(15)(q11) RAB 15-O-q11/1-33
55 47,XY,+mar[100%] n.a. inv dup(15)(q11) FP, ICSI 15-O-q11/1-34 
56 47,XY,+mar[100%] n.a. inv dup(15)(q11) FP, ICSI 15-O-q11/1-35
57 47,XY,+mar[100%] n.a. inv dup(15)(q11) OAT 15-O-q11/1-37
58 48,XY,+2mar[100%] Maternal inv dup(15)(q11)x2 RAB 15-O-q11/2-1
(1 sSMC only)
59 48,XX,+2mar[100%] Paternal inv dup(15)(q11)x2 FP 15-O-q11/2-2
(1 sSMC only)
60 48,XX,+2mar[100%] de novo inv dup(15)(q11)x2 FP 15-O-q11/2-3
61 47,XY,+mar[100%] n.a. min(15)(p11->q11) Oligospermia 15-O-q11/4-1
62 47,XX,+mar[?%]/ n.a. inv dup(15)(q11.1) FP, ICSI 15-O-q11.1/1-1
46,XX[?%]
63 47,XX,+mar[100%] n.a. inv dup(15)(q11.1) Amenorrhea 15-O-q11.1/1-6
64 47,XY,+mar[100%] Maternal inv dup(15)(q11.1) Azoospermia 15-O-q11.1/1-35
65 47,XY,+mar[100%] Maternal inv dup(15)(q11.1) Azoospermia 15-O-q11.1/1-36
66 47,XY,+mar[100%] Maternal inv dup(15)(q11.1) Azoospermia 15-O/q11.1/1-37
67 47,XY,+mar[100%] Paternal inv dup(15)(q11.1) OAT, seminoma 15-O-q11.1/1-38
68 47,XY,+mar[100%] de novo inv dup(15)(q11.1) Azoospermia 15-O-q11.1/1-39
69b 47,XY,+mar[100%] n.a. inv dup(15)(q11.1) OAT 15-O-q11.1/1-41
70 47,XY,+mar[100%] Familial inv dup(15)(q11.1) OAT (familial) 15-O-q11.1/1-42
71b 47,XX,+mar[?100%] n.a. inv dup(15)(q11.1) Primary amenorrhea 15-O-q11.1/1-45
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Table I. Continued.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Case GTG-result Parental FISH result Clinical findings sSMC no.
no. origin according to (8)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
72b 47,XX,+mar[23%]/ n.a. inv dup(15)(q11.1) RAB 15-O-q11.1/1-46
46,XX[77%]
73 48,XX,+2mar[80%]/ de novo 2 x inv dup(15)(q11.1) RAB (familial) 15-O-q11.1/2-1
46,XX[20%]
74b 48,XY,+2mar[100%] Maternal 2 x inv dup(15)(q11.1) Oligospermia 15-O-q11.1/2-2
75b 47,XY,+mar[?%]/ n.a. r(15)(::p1?2->q11.1::) Severe OAT, ICSI 15-O-q11.1/5-1
46,XY[?%]
76 47,XY,+mar[100%] Familial inv dup(15)(q11.2) Oligospermia 15-O-q11.2/1-4
77 47,XX,+mar[100%] Maternal and inv dup(15)(q11.2) RAB 15-O-q11.2/1-5
grandpaternal
78 48,XY,+2mar[100%] n.a. inv dup(15)(q11.2)x2 OAT 15-O-q11.2/3-2
79 47,XY,+mar[98%]/ n.a. min(15)(:p13->q11.2:) RAB 15-O-q11.2/2-3
46,XY[2%]
80 47,XY,+mar[100%] n.a. inv dup(15)(q11.2~q12) FP 15-O-q11.2 ~12/1-1
81b 47,XY,+mar[?100%] n.a. inv dup(15)(q11.2~q12) RAB in female partner 15-O-q11.2 ~12/1-3
82 47,XY,+mar[100%] n.a. inv dup(15)(q11.2~q13) Oligospermia 15-CO-2
83 47,XY,+mar[100%] n.a. min(15) RAB 15-CO-24
84 47,XY,+mar[?100%] n.a. mar(15) FP 15-CO-47
85 47,XY,+mar[100%] n.a. inv dup(15) Oligozoospermia 15-CO-64
86 47,XY,+mar[100%] n.a. inv dup(15) Oligozoospermia 15-CO-67
87 47,XY,+mar[100%] n.a. inv dup(15) FP 15-CO-68
88 47,XY,+mar[100%] n.a. inv dup(15) Severe OAT 15-CO-69
89 47,XY,+mar[100%] n.a. inv dup(15) Severe OAT 15-CO-70
90 47,XY,+mar[100%] n.a. inv dup(15) Cryptozoospermia 15-CO-71
91 47,XY,+mar[100%] n.a. inv dup(15) FP in female partner 15-CO-72
92 47,XY,+mar[100%] n.a. inv dup(15) Sperm donor 15-CO-73
93 47,XY,+mar[60%]/ Paternal r(16) RAB 16-CO-4
46,XY[40%]
94 47,XY,+mar[67%]/ de novo min(17)(:p11.2->q11.1:) Asthenospermia, ICSI 17-O-p11.2/1-1
46,XY[33%]
95 47,XX,+mar[58%]/ n.a. min(18)(:p11.21->q11.1:) FP, ICSI 18-O-p11.21/1-1
46,XX[42%]
96b 47,XX,+mar[87%]/ de novo mar(20) - for exact FP 20-O-p11.21/1-1
46,XX[13%] karyotype see belowc
97 47,XY,+mar mat[4%]/ Maternal mar(20) RAB 20-CO-1
46,XY[96%]
98 47,XY,+mar[80%]/ de novo mar(20) Azoospermia 20-CO-2
46,XY[20%]
99 47,XY,+mar[100%] n.a. r(21)(::p11.2->q21.1::) RAB in female partner 21-O-q21.1/2-1
100 47,XX,+mar[100%] n.a. inv dup(22)(q11) FP 22-O-q11/1-1
101 47,XX,+mar[100%] n.a. inv dup(22)(q11.1) FP 22-O-q11.1/1-7
102b 47,XX,+mar[100%] n.a. inv dup(22)(q11.1) RAB 22/O-q11.1/1-8
103b 47,XX,+mar[100%] n.a. inv dup(22)(q11.1) FP 22/O-q11.1/1-10




105 47,XY,+mar[100%] n.a. inv dup(22) FP, ICSI 22-CO-7
106 47,XX,+mar[?%]/ n.a. r(Y)(::p11.1->?q11.2::) FP 0Y-O-1
46,XX[?%]
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‘patients with fertility problems’, however, there might be a
tendency for amenorrhea or defined abnormalities in the
gametes to appear in correlation with acrocentric sSMC and
repeated abortions in correlation with non-acrocentric sSMC
(Fig. 3b).
Fertility problems in sSMC carriers and evolutionary effects.
Familial as well as de novo sSMC can be associated with
fertility problems (Fig. 5). Thus, this observation suggests
evolutionary selection against aneuploidy caused by sSMC
presence, e.g. similar to that existing in males with karyotype
47,XXY (14). Several mechanisms seem to be involved here.
(i) It has been shown repeatedly (12,15) that sSMC are more
likely to be carried forward through the maternal line, thus,
selection for gametes without an additional extra chromo-
some during oogensis can be postulated [for more details see
also (12); for centromeric drive see (16)]. (ii) It has also been
suggested that any kind of chromosomal aberration can
reduce the ability of correct chromosomal pairing during
meiosis I (1), which can cause fertility problems especially in
males (17). (iii) There are indications that OAT/oligozoo-
spermia is significantly correlated with sSMC presence (7%),
while azoospermia and sSMC are correlated in <1% of the
corresponding cases (18). (iv) There could also be mechanisms
that reduce the percentage of sSMC carrying gametes, as
proven for several cases [8 cases: 15-O-q11.1/1-42, 15-O-
q11.2/2-3, 15-CO-67 to 72 (19)]. (v) An enhanced rate of
repeated abortions in sSMC carriers or their partners was
observed in 22-35% of the cases collected here (Table I;
Fig. 3); in these cases uniparental disomy (UPD) of the sister
chromosomes might be a possible explanation, even though
such UPD was up to now only proven for de novo sSMC
cases. (vi) Finally the influence of epigenetic factors (13) is
possible, according to the data presented in Fig. 5b, however,
the exact mechanism remains unclear.
Male/female rate in infertile sSMC carriers. As already
mentioned, population studies of otherwise healthy persons
with unexplained infertility, revealed that there is a detection
rate of 0.125% for sSMC, which is ~2.9-fold higher than in
the normal population (4). Notably, the detection rate was
0.165% in males and 0.022% in females (4), i.e. there was a
7.5-fold difference. This observation is not confirmed by this
study, as among those cases in which the origin of the sSMC
was determined, there are 71 male and 40 female patients
with fertility problems. Thus, both observations are assuredly
biased by the heterogeneous reasons which can lead to
inclusion in the group ‘infertility patients’ for cytogenetic
study.
Conclusion
sSMC presence is enhanced in the heterogeneous group
‘patients with fertility problems’ about 3-fold compared to
the normal population. Here for the first time, 111 such
patients studied for the chromosomal origin of their sSMC
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–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Case GTG-result Parental FISH result Clinical findings sSMC no.
no. origin according to (8)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
107 47,XX,+mar[100%] Maternal dic(13 or 21;14)(q10;q10) RAB 13/21-O-q10/4-1
and 14-O-q10/2-1
108 47,XY,+mar[100%] Maternal der(15)t(9;15)(p24;q11.2) RAB in female partner 15-O-q11.2/5-1
109 47,XX,+mar[100%] n.a. dic(Y;15) FP 15-CO-1
and 0Y-CO-2
110b 47,XY,+mar[78%]/ n.a. inv dup (acro)(p10) FP, ICSI acro-O-4
46,XY[22%]
111b 47,XY,+mar[25%]/ n.a. inv dup (acro)(p10) OAT acro-O-5
46,XY[75%]
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aThe cases are listed according to their chromosomal origin (from 1-22, X,Y). The explanation for the numbering of sSMC cases in (8) is
given in http://www.med.uni-jena.de/fish/sSMC/pageinfo.htm. bCase of the present study.





mar6: inv dup(20)(:20p11.1->20p11.21::20q11.21->20p11.1: :20p11.1->20q11.21: :20p11.21->20p11.1:)[1]/
mar7: inv dup(20)(:20q11.1->20q11.21::20p11.21->20q11.1: :20q11.1->20p11.21:)[1]/
mar8: inv dup(20)(:20q11.1->20q11.21: :20p11.21->20q11.1::20q11.1->20p11.1:)[1]
48 chromosomes: mar9: min(20)(:20q11.1->20p11.21::20q11.21->20q11.1:) +
mar4: r(20)(::20p11.1->20q11.21::20p11.1->20q11.21::)[1]
FP, fertility problems/unexplained infertility; ICSI, intracytoplasmatic sperm injected treatment patient; n.a., not available; OAT,
oligoasthenoteratozoospermia; RAB, repeated abortions. Note: The abbreviation ‘min’ is applied according to (20) and not to (21).
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
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revealed that chromosomes 14 and 15 were the most
frequently involved. In about 30% of these cases euchromatic
imbalances were caused by the sSMC presence. Unexpectedly,
over 50% of the patients with fertility problems and sSMC
presence inherited their marker chromosome from one of
their parents. It has to be considered whether this could be in
connection with a yet unknown evolutionary selection effect
towards the elimination of sSMC from the human gene
pool. Thus, sSMC could play an important role in our
understanding of the processes involved in chromosome gain
and loss during evolution.
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